AG˹ٷ

STOCK TITAN

GLOBE LIFE INC. REPORTS FIRST QUARTER 2025 RESULTS

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Globe Life reported strong Q1 2025 financial results, with net income reaching $3.01 per diluted share, up from $2.67 in the year-ago quarter. Net operating income rose to $3.07 per share, exceeding management's expectations.

Key highlights include:

  • Net income ROE of 19.0%
  • 13% increase in net income per share
  • 10% increase in net operating income per share
  • 6% growth in American Income Life Division premiums
  • 9% increase in life underwriting margin

The company's insurance operations showed solid performance, with life insurance accounting for 80% of underwriting margin and 69% of premium revenue. Health insurance contributed 20% of underwriting margin and 31% of premium revenue. Total premium revenue increased by 5% to $1.2 billion. During the quarter, Globe Life repurchased 1.5 million shares at a total cost of $177 million.

Globe Life ha riportato risultati finanziari solidi per il primo trimestre 2025, con un utile netto di 3,01 dollari per azione diluita, in aumento rispetto ai 2,67 dollari dello stesso periodo dell'anno precedente. L'utile operativo netto è salito a 3,07 dollari per azione, superando le aspettative della direzione.

I punti salienti includono:

  • ROE sull'utile netto del 19,0%
  • Aumento del 13% dell'utile netto per azione
  • Crescita del 10% dell'utile operativo netto per azione
  • Incremento del 6% dei premi nella divisione American Income Life
  • Aumento del 9% del margine di sottoscrizione vita

Le attività assicurative dell'azienda hanno mostrato una performance solida, con l'assicurazione sulla vita che rappresenta l'80% del margine di sottoscrizione e il 69% dei ricavi da premi. L'assicurazione sanitaria ha contribuito per il 20% al margine di sottoscrizione e per il 31% ai ricavi da premi. Il totale dei ricavi da premi è aumentato del 5%, raggiungendo 1,2 miliardi di dollari. Durante il trimestre, Globe Life ha riacquistato 1,5 milioni di azioni per un costo complessivo di 177 milioni di dollari.

Globe Life reportó sólidos resultados financieros en el primer trimestre de 2025, con un ingreso neto de 3,01 dólares por acción diluida, frente a los 2,67 dólares del mismo trimestre del año anterior. El ingreso operativo neto aumentó a 3,07 dólares por acción, superando las expectativas de la gerencia.

Los puntos clave incluyen:

  • ROE del ingreso neto del 19,0%
  • Aumento del 13% en el ingreso neto por acción
  • Crecimiento del 10% en el ingreso operativo neto por acción
  • Crecimiento del 6% en las primas de la división American Income Life
  • Aumento del 9% en el margen de suscripción de vida

Las operaciones de seguros de la compañía mostraron un desempeño sólido, con el seguro de vida representando el 80% del margen de suscripción y el 69% de los ingresos por primas. El seguro de salud contribuyó con el 20% del margen de suscripción y el 31% de los ingresos por primas. Los ingresos totales por primas aumentaron un 5% hasta 1,2 mil millones de dólares. Durante el trimestre, Globe Life recompró 1.5 millones de acciones por un costo total de 177 millones de dólares.

Globe Life� 2025� 1분기� 강력� 재무 실적� 보고했으�, 희석 주당 순이익이 전년 동기 2.67달러에서 3.01달러� 증가했습니다. 순영업이익은 주당 3.07달러� 경영진의 기대치를 초과했습니다.

주요 내용은 다음� 같습니다:

  • 순이� 자기자본이익�(ROE) 19.0%
  • 주당 순이� 13% 증가
  • 주당 순영업이� 10% 증가
  • American Income Life 부� 보험� 6% 성장
  • 생명보험 인수 마진 9% 증가

회사� 보험 사업은 견고� 실적� 보였으며, 생명보험은 인수 마진� 80%, 보험� 수입� 69%� 차지했습니다. 건강보험은 인수 마진� 20%, 보험� 수입� 31%� 기여했습니다. � 보험� 수입은 5% 증가하여 12� 달러� 달했습니�. 분기 동안 Globe Life� � 1� 7,700� 달러� 들여 150� 주를 자사� 매입했습니다.

Globe Life a annoncé de solides résultats financiers pour le premier trimestre 2025, avec un bénéfice net atteignant 3,01 $ par action diluée, en hausse par rapport à 2,67 $ au même trimestre de l'année précédente. Le bénéfice d'exploitation net a augmenté pour atteindre 3,07 $ par action, dépassant les attentes de la direction.

Les points clés comprennent :

  • ROE du bénéfice net de 19,0 %
  • Augmentation de 13 % du bénéfice net par action
  • Augmentation de 10 % du bénéfice d'exploitation net par action
  • Croissance de 6 % des primes de la division American Income Life
  • Augmentation de 9 % de la marge de souscription vie

Les opérations d'assurance de la société ont montré une performance solide, l'assurance vie représentant 80 % de la marge de souscription et 69 % des revenus de primes. L'assurance santé a contribué à hauteur de 20 % à la marge de souscription et 31 % aux revenus de primes. Le revenu total des primes a augmenté de 5 % pour atteindre 1,2 milliard de dollars. Au cours du trimestre, Globe Life a racheté 1,5 million d'actions pour un coût total de 177 millions de dollars.

Globe Life meldete starke Finanzergebnisse für das erste Quartal 2025, mit einem Nettogewinn von 3,01 USD je verwässerter Aktie, gegenüber 2,67 USD im Vorjahresquartal. Der operative Nettogewinn stieg auf 3,07 USD je Aktie und übertraf damit die Erwartungen des Managements.

Wichtige Highlights sind:

  • Eigenkapitalrendite (ROE) des Nettogewinns von 19,0 %
  • 13 % Steigerung des Nettogewinns je Aktie
  • 10 % Zunahme des operativen Nettogewinns je Aktie
  • 6 % Wachstum der Prämien in der American Income Life Division
  • 9 % Anstieg der Lebensversicherungs-Unterwriting-Marge

Die Versicherungsgeschäfte des Unternehmens zeigten eine solide Leistung, wobei die Lebensversicherung 80 % der Underwriting-Marge und 69 % der Prämieneinnahmen ausmachte. Die Krankenversicherung trug 20 % zur Underwriting-Marge und 31 % zu den Prämieneinnahmen bei. Die gesamten Prämieneinnahmen stiegen um 5 % auf 1,2 Milliarden USD. Im Quartal kaufte Globe Life 1,5 Millionen Aktien zu Gesamtkosten von 177 Millionen USD zurück.

Positive
  • Net income per share increased 13% to $3.01 vs $2.67 year-ago quarter
  • Net operating income per share rose 10% to $3.07, exceeding management expectations
  • Strong ROE of 19.0% for Q1 2025
  • Life underwriting margin increased 9% year-over-year
  • American Income Life premiums grew 6% over year-ago quarter
  • Liberty National showed 4% increase in life sales and 8% growth in producing agents
  • Family Heritage Division health sales up 7% with 9% premium growth
  • Total health insurance net sales increased 24% year-over-year
Negative
  • Excess investment income declined 18% to $35.9M from $43.8M year-ago
  • Interest on debt increased 37% year-over-year
  • Health insurance underwriting margin decreased 10% vs year-ago quarter
  • Direct to Consumer life net sales declined 12%
  • Administrative expense ratio increased to 7.3% from 7.0% year-ago
  • United American health underwriting margin dropped 86%
  • Direct to Consumer health segment reported negative underwriting margin of -8%

Insights

Globe Life delivers strong Q1 with 13% EPS growth and 10% operating income growth despite some challenges in health segment.

Globe Life's Q1 2025 results demonstrate solid financial performance with net income reaching $3.01 per diluted share, a 13% increase over the year-ago quarter. Net operating income rose 10% to $3.07 per share, exceeding management's expectations. The company reported robust profitability metrics with net income ROE of 19.0% and net operating income ROE (excluding AOCI) of 14.1%.

Premium revenue showed healthy growth across both segments, with total premiums rising 5% year-over-year. Life insurance premiums increased 3% while health insurance premiums grew by 8%. The life underwriting margin improved significantly, increasing 9% over the year-ago quarter.

The company's capital allocation strategy continues to favor shareholders, with 1.5 million shares repurchased at a total cost of $177 million during the quarter, helping drive per-share metrics higher.

Some areas warrant attention: health underwriting margin decreased 10% compared to the year-ago quarter, with United American division experiencing a substantial drop from 8% to 1% of premium. Administrative expenses as a percentage of premium increased to 7.3% from 7.0%. Net investment income declined 1%, and the company recorded $4.8 million in expenses related to legal proceedings.

Despite these challenges, the overall financial performance demonstrates the company's ability to grow earnings effectively across its diversified business lines.

GL shows strong life insurance performance with 9% margin growth, offsetting concerning health segment challenges in United American division.

Globe Life's Q1 2025 insurance operations reveal a tale of two segments. Life insurance showed excellent performance with underwriting margin increasing 9% year-over-year, reaching 41% of premium versus 38% previously. Conversely, health insurance underwriting margin declined 10%, dropping to 23% of premium from 27%.

Division performance varies significantly. American Income Life, the largest contributor, delivered consistent results with life premiums up 6% and maintained a strong 45% underwriting margin. Liberty National showed solid growth with net life sales up 4%, life premiums up 6%, and 8% increase in agent count, though life underwriting margin slightly decreased to 33%.

Family Heritage posted impressive health insurance results with premiums up 9%, net sales up 7%, and agent count increased 9%, maintaining a 35% underwriting margin.

Two concerning datapoints demand attention: United American's health underwriting margin dramatically declined from 8% to 1%, and Direct to Consumer recorded a negative health underwriting margin of -8% compared to 1% in the year-ago quarter.

Agent metrics show average producing agent counts increased at American Income (3%), Liberty National (8%), and Family Heritage (9%). The ratio of administrative expenses to premium increased to 7.3% from 7.0%.

Overall insurance underwriting income grew 4%, demonstrating that strength in life insurance effectively balanced weaknesses in certain health segments.

MCKINNEY, Texas, April 30, 2025 /PRNewswire/ -- Globe Life Inc. (NYSE: GL) reported today that for the quarter ended March 31, 2025, net income was $3.01 per diluted common share, compared with $2.67 per diluted common share for the year-ago quarter. Net operating income was $3.07 per diluted common share, above management's expectations, compared with $2.78 per diluted common share for the year-ago quarter.

HIGHLIGHTS:

  • Net income as an ROE was 19.0% for the three months ended March 31, 2025. Net operating income as an ROE excluding accumulated other comprehensive income (AOCI) was 14.1% for the same period.
  • Net income per share increased 13% and net operating income per share increased 10% over the year-ago quarter.
  • At the American Income Life Division, life premiums increased over the year-ago quarter by 6%.
  • At the Liberty National Division, net life sales increased 4% and life premiums increased 6% over the year-ago quarter. Additionally, the average producing agent count increased 8% over the year-ago quarter.
  • At the Family Heritage Division, health net sales increased 7% and health premiums increased 9% over the year-ago quarter. Additionally, the average producing agent count increased 9% over the year-ago quarter.
  • Life underwriting margin increased 9% over the year-ago quarter.
  • 1.5 million shares of Globe Life Inc. common stock at a total cost of $177 million were repurchased during the quarter.

Note: As used in the earnings release, "Globe Life," the "Company," "we," "our," and "us" refer to Globe Life Inc., a Delaware corporation incorporated in 1979, its subsidiaries and affiliates.

GLOBE LIFE INC.

Earnings Release—Q1 2025

(Dollar amounts in thousands, except share and per share data)

(Unaudited)


RESULTS OF OPERATIONS


Net operating income, a non-GAAP(1) financial measure, has been used consistently by Globe Life's management for many years to evaluate the operating performance of the Company, and is a measure commonly used in the life insurance industry. It differs from net income primarily because it excludes certain non-operating items such as realized investment gains and losses and certain significant and unusual items included in net income. Management believes an analysis of net operating income is important in understanding the profitability and operating trends of the Company's business. Net income is the most directly comparable GAAP measure.


The following table represents Globe Life's operating summary for the three months ended March 31, 2025 and 2024:


Operating Summary


Per Share








Three Months Ended

March 31,




Three Months Ended

March 31,




2025


2024


%

Chg.


2025


2024


%

Chg.

Insurance underwriting income(2)

$ 3.98


$ 3.41


17


$ 336,315


$ 324,361


4

Excess investment income(2)

0.42


0.46


(9)


35,870


43,785


(18)

Interest on debt

(0.41)


(0.30)


37


(34,992)


(28,621)


22

Parent company expense

(0.04)


(0.03)




(3,050)


(2,826)



Income tax expense

(0.77)


(0.70)


10


(64,891)


(66,227)


(2)

Stock compensation benefit (expense), net of tax

(0.12)


(0.07)




(9,915)


(6,373)



Net operating income

3.07


2.78


10


259,337


264,099


(2)













Reconciling items, net of tax:












AG˹ٷized gain (loss)


(0.10)




67


(9,321)



Non-operating expenses


(0.01)





(561)



Legal proceedings(4)

(0.06)





(4,841)




Net income(3)

$ 3.01


$ 2.67




$ 254,563


$ 254,217















Weighted average diluted shares outstanding

84,480


95,115











(1)

GAAP is defined as accounting principles generally accepted in the United States of America.

(2)

Definitions included within this document.

(3)

A GAAP-basis condensed consolidated statement of operations is included in the appendix of this report.

(4)

Includes an estimate of costs associated with settlement of certain litigation claims not related to the Department of Justice, Securities and Exchange Commission, or Equal Employment Opportunity Commission matters, as well as certain additional legal expenses incurred.



Note: Tables in this earnings release may not sum due to rounding.

GLOBE LIFE INC.

Earnings Release—Q1 2025

(Dollar amounts in thousands, except share and per share data)

(Unaudited)


MANAGEMENT VS. GAAP MEASURES


Shareholders' equity, excluding AOCI, and book value per share, excluding AOCI, are non-GAAP measures that are utilized by management to view the business without the effect of changes in AOCI, which are primarily attributable to fluctuation in interest rates. Management views the business in this manner because it creates more meaningful and easily identifiable trends, as we exclude fluctuations resulting from changes in interest rates. Shareholders' equity and book value per share are the most directly comparable GAAP measures.




Three Months Ended

March 31,


2025


2024

Net income

$ 254,563


$ 254,217

Net operating income

259,337


264,099

Net income as an ROE(1)

19.0%


21.3%

Net operating income as an ROE(excluding AOCI)(1)

14.1%


14.3%






March 31,


2025


2024

Shareholders' equity

$ 5,425,416


$ 5,039,161

Impact of adjustment to exclude AOCI

1,970,873


2,467,236

Shareholders' equity, excluding AOCI

$ 7,396,289


$ 7,506,397





Book value per share

$ 64.50


$ 53.03

Impact of adjustment to exclude AOCI

23.42


25.97

Book value per share, excluding AOCI

$ 87.92


$ 79.00



(1)

Calculated using average shareholders' equity for the measurement period.

GLOBE LIFE INC.

Earnings Release—Q1 2025

(Dollar amounts in thousands, except share and per share data)

(Unaudited)


INSURANCE OPERATIONS:


Life insurance accounted for 80% of the Company's insurance underwriting margin for the quarter and 69% of total premium revenue.


Health insurance accounted for 20% of the Company's insurance underwriting margin for the quarter and 31% of total premium revenue.


Net sales of life insurance declined 1% for the quarter, while net health sales increased 24%.


The following table summarizes Globe Life's premium revenue by product type for the three months ended March 31, 2025 and 2024:


Insurance Premium Revenue


Quarter Ended


March 31, 2025


March 31, 2024


%

Chg.

Life insurance

$ 829,863


$ 804,265


3

Health insurance

369,791


341,019


8

Total

$ 1,199,654


$ 1,145,284


5


INSURANCE UNDERWRITING INCOME

Insurance underwriting margin is management's measure of profitability of the Company's life and health segments' underwriting performance, and consists of premiums less policy obligations (excluding interest on policy liabilities), commissions and other acquisition expenses. Insurance underwriting income is the sum of the insurance underwriting margins of the life and health segments, plus annuity and other income, less administrative expenses. It excludes the investment segment, interest on debt, Parent Company expense, stock compensation expense and income taxes. Management believes this information helps provide a better understanding of the business and a more meaningful analysis of underwriting results by distribution channel. Insurance underwriting income, a non-GAAP measure, is a component of net operating income, which is reconciled to net income in the Results of Operations section above.

The following table summarizes Globe Life's insurance underwriting income by segment for the three months ended March 31, 2025 and 2024:

Insurance Underwriting Income


Quarter Ended


March 31, 2025


% of

Premium


March 31, 2024


% of

Premium


%

Chg.

Insurance underwriting margins:










Life

$ 337,264


41


$ 309,011


38


9

Health

84,721


23


93,770


27


(10)


421,985




402,781




5

Annuity and other income

1,879




1,991





Administrative expenses

(87,549)




(80,411)





Insurance underwriting income

$ 336,315




$ 324,361




4

Per share

$ 3.98




$ 3.41




17


The ratio of administrative expenses to premium was 7.3%, compared with 7.0% for the year-ago quarter.

GLOBE LIFE INC.

Earnings Release—Q1 2025

(Dollar amounts in thousands, except share and per share data)

(Unaudited)


LIFE INSURANCE RESULTS BY DISTRIBUTION CHANNEL


Our distribution channels consist of the following exclusive divisions: American Income Life Division (American Income), Liberty National Division (Liberty National), Family Heritage Division (Family Heritage), Direct to Consumer Division (Direct to Consumer); and an independent agency, United American Division (United American).


Total premium, underwriting margins, first-year collected premium and net sales by all distribution channels are shown at at "Financial Reports and Other Financial Information."



Life Underwriting Margin


Quarter Ended




March 31,




2025


2024




Amount


% of
Premium


Amount


% of
Premium


%
Chg.

American Income

$ 196,169


45


$ 187,068


45


5

Direct to Consumer

64,200


26


58,585


24


10

Liberty National

31,772


33


30,713


34


3

Other

45,123


90


32,645


64


38

Total

$ 337,264


41


$ 309,011


38


9

Life Premium


Quarter Ended




March 31,




2025


2024


%

Chg.

American Income

$ 437,866


$ 414,044


6

Direct to Consumer

245,600


248,040


(1)

Liberty National

96,182


90,777


6

Other

50,215


51,404


(2)

Total

$ 829,863


$ 804,265


3


Life Net Sales(1)


Quarter Ended




March 31,




2025


2024


%

Chg.

American Income

$ 98,555


$ 97,195


1

Direct to Consumer

25,175


28,563


(12)

Liberty National

22,469


21,605


4

Other

2,152


2,134


1

Total

$ 148,351


$ 149,497


(1)



(1)

Net sales is calculated as annualized premium issued, net of cancellations in the first thirty days after issue, except in the case of Direct to Consumer, where net sales is annualized premium issued at the time the first full premium is paid after any introductory offer period (typically 1 month) has expired. Management considers net sales to be a better indicator of the rate of premium growth than annualized premium issued since annualized premium issued excludes cancellations, and cancellations do not contribute to premium income.

GLOBE LIFE INC.

Earnings Release—Q1 2025

(Dollar amounts in thousands, except share and per share data)

(Unaudited)


HEALTH INSURANCE RESULTS BY DISTRIBUTION CHANNEL



Health Underwriting Margin


Quarter Ended




March 31,




2025


2024




Amount


% of
Premium


Amount


% of
Premium


%
Chg.

United American

$ 1,617


1


$ 11,906


8


(86)

Family Heritage

39,249


35


35,838


35


10

Liberty National

25,982


54


26,672


56


(3)

American Income

19,389


63


19,192


63


1

Direct to Consumer

(1,516)


(8)


162


1



Total

$ 84,721


23


$ 93,770


27


(10)

Health Premium


Quarter Ended




March 31,




2025


2024


%

Chg.

United American

$ 159,848


$ 141,635


13

Family Heritage

112,354


103,391


9

Liberty National

47,922


47,630


1

American Income

30,691


30,497


1

Direct to Consumer

18,976


17,866


6

Total

$ 369,791


$ 341,019


8


Health Net Sales(1)


Quarter Ended




March 31,




2025


2024


%

Chg.

United American

$ 27,708


$ 16,423


69

Family Heritage

26,816


24,966


7

Liberty National

7,198


7,613


(5)

American Income

4,870


4,594


6

Direct to Consumer

645


804


(20)

Total

$ 67,237


$ 54,400


24



(1)

Net sales is calculated as annualized premium issued, net of cancellations in the first thirty days after issue, except in the case of Direct to Consumer, where net sales is annualized premium issued at the time the first full premium is paid after any introductory offer period (typically 1 month) has expired. Management considers net sales to be a better indicator of the rate of premium growth than annualized premium issued since annualized premium issued excludes cancellations, and cancellations do not contribute to premium income.

GLOBE LIFE INC.

Earnings Release—Q1 2025

(Dollar amounts in thousands, except share and per share data)

(Unaudited)


PRODUCING EXCLUSIVE AGENT COUNT RESULTS BY DISTRIBUTION CHANNEL




Quarterly Average

Producing Agent Count(1)


Quarter Ended




Quarter Ended


March 31,




December 31,


2025


2024


%
Chg.


2024

American Income

11,510


11,139


3


11,926

Liberty National

3,688


3,419


8


3,743

Family Heritage

1,417


1,295


9


1,512



(1)

The quarterly average producing agent count is based on the actual count at the beginning and end of each week during the period.



INVESTMENTS

Management uses excess investment income as the measure to evaluate the performance of the investment segment. It is defined as net investment income less the required interest attributable to policy liabilities. We also view excess investment income per diluted common share as an important and useful measure to evaluate performance of the investment segment, since it takes into consideration our stock repurchase program.

The following table summarizes Globe Life's investment income, excess investment income, and excess investment income per diluted common share.

Excess Investment Income


Quarter Ended


March 31,


2025


2024


%

Chg.

Net investment income

$ 280,614


$ 282,578


(1)

Interest on policy liabilities(1)

(244,744)


(238,793)


2

Excess investment income

$ 35,870


$ 43,785


(18)

Per share

$ 0.42


$ 0.46


(9)



(1)

Interest on policy liabilities, at original discount rates, is a component of total policyholder benefits, a GAAP measure.



Net investment income declined 1% while average invested assets increased 1%. Required interest on policy liabilities and average policy liabilities both increased 2%.

GLOBE LIFE INC.

Earnings Release—Q1 2025

(Dollar amounts in thousands, except share and per share data)

(Unaudited)


The composition of the investment portfolio at book value at March 31, 2025 is as follows:


Investment Portfolio


As of


March 31, 2025


Amount


% of Total

Fixed maturities at fair value(1)

$ 17,504,967


87

Mortgage loans

426,174


2

Policy loans

708,175


4

Other long-term investments(2)

1,236,624


6

Short-term investments

134,066


1

Total

$ 20,010,006





(1)

As of March 31, 2025, fixed maturities at amortized cost were $19.0 billion, net of $10.4 million of allowance for credit losses.

(2)

Includes $989 million of investments accounted for under the fair value option which have a cost of $969 million as of March 31, 2025.



Fixed maturities at amortized cost, net of allowance for credit losses, by asset class as of March 31, 2025 are as follows:

Fixed Maturity Portfolio by Sector


As of


March 31, 2025


Investment
Grade


Below
Investment
Grade


Total
Amortized
Cost, net

Corporate bonds

$ 14,634,347


$ 460,971


$ 15,095,318

Municipals

3,295,133



3,295,133

Government, agencies, and GSEs(1)

445,527



445,527

Collateralized debt obligations


36,609


36,609

Other asset-backed securities

82,646


8,779


91,425

Total

$ 18,457,653


$ 506,359


$ 18,964,012



(1)

Government-Sponsored Enterprises



Below are fixed maturities available for sale by amortized cost, allowance for credit losses, and fair value at March 31, 2025 and the corresponding amounts of net unrealized gains and losses recognized in accumulated other comprehensive income (loss).

As of

Amortized

Cost


Allowance for
Credit Losses


Net Unrealized
Gains
(Losses)


Fair

Value

March 31, 2025

$ 18,974,367


$ (10,355)


$ (1,459,045)


$ 17,504,967









At amortized cost, net of allowance for credit losses, 97% of fixed maturities (97% at fair value) were rated "investment grade." The fixed maturity portfolio earned an annual taxable equivalent effective yield of 5.25% during the first quarter of 2025, compared with 5.24% in the year-ago quarter.

Globe Life is not a party to any credit default swaps and does not participate in securities lending.

GLOBE LIFE INC.

Earnings Release—Q1 2025

(Dollar amounts in thousands, except share and per share data)

(Unaudited)


Comparable information for acquisitions of fixed maturity and other investments is as follows:


Fixed Maturity Acquisitions


Quarter Ended


March 31,


2025


2024

Amount

$ 244,845


$ 682,427

Average annual effective yield

6.4%


5.9%

Average rating

A-


A-

Average life (in years) to:




Next call

40.7


30.4

Maturity

43.1


32.3





Other Investment Acquisitions


Quarter Ended


March 31,


2025


2024

Limited partnerships

$ 15,831


$ 67,498

Mortgage loans

35,621


58,406

Common stock

502


11,968

Other invested assets


1,350

Total

$ 51,954


$ 139,222


SHARE REPURCHASE:

During the quarter, the Company repurchased 1.5 million shares of Globe Life Inc. common stock at a total cost of $177 million and an average share price of $121.70.

LIQUIDITY/CAPITAL:

Globe Life's operations consist primarily of writing basic protection life and supplemental health insurance policies which generate strong and stable cash flows. These cash flows are not impacted by volatile equity markets. Liquidity at the Parent Company is sufficient to meet additional capital needs of the insurance companies.

EARNINGS GUIDANCE FOR THE YEAR ENDING DECEMBER 31, 2025:

Globe Life projects net operating income between $13.45 to $14.05 per diluted common share for the year ending December 31, 2025, reaffirming the previous guidance.

NON-GAAP MEASURES:

In this news release, Globe Life includes non-GAAP measures to enhance investors' understanding of management's view of the business. The non-GAAP measures are not a substitute for GAAP, but rather a supplement to increase transparency by providing broader perspective. Globe Life's definitions of non-GAAP measures may differ from other companies' definitions. More detailed financial information, including various GAAP and non-GAAP measurements, is located at on the Investors page under "Financial Reports and Other Financial Information."

CAUTION REGARDING FORWARD-LOOKING STATEMENTS:

This press release may contain forward-looking statements within the meaning of the federal securities laws. These prospective statements reflect management's current expectations, but are not guarantees of future performance. Whether or not actual results differ materially from forward-looking statements may depend on numerous foreseeable and unforeseeable events or developments, which may be national in scope, related to the insurance industry generally, or applicable to the Company specifically. Such events or developments could include, but are not necessarily limited to:

1) Economic and other conditions, including the impact of inflation, immigration, geopolitical events, escalating tariff and non-tariff trade measures imposed by the U.S. and other countries, and other governmental actions on the U.S. economy and/or U.S. consumer confidence, leading to unexpected changes in lapse rates and/or sales of our policies, as well as levels of mortality, morbidity, and utilization of health care services that differ from Globe Life's assumptions;

2) Regulatory developments, including changes in accounting standards or governmental regulations (particularly those impacting taxes and changes to the Federal Medicare program that would affect Medicare Supplement);

3) Market trends in the senior-aged health care industry that provide alternatives to traditional Medicare (such as Health Maintenance Organizations and other managed care or private plans) and that could affect the sales of traditional Medicare Supplement insurance;

4) Interest rate changes that affect product sales, financing costs, and/or investment yields;

5) General economic, industry sector or individual debt issuers' financial conditions (including developments and volatility arising from geopolitical events, particularly in certain industries that may compromise part of our investment portfolio) that may affect the current market value of securities we own, or that may impair an issuer's ability to make principal and/or interest payments due on those securities;

6) Changes in the competitiveness of the Company's products and pricing;

7) Litigation results;

8) Levels of administrative and operational efficiencies that differ from our assumptions (including any reduction in efficiencies resulting from increased costs arising from the impact of higher than anticipated inflation);

9) The ability to obtain timely and appropriate premium rate increases for health insurance policies from our regulators;

10) The customer response to new products and marketing initiatives;

11) Reported amounts in the consolidated financial statements which are based on management estimates and judgments which may differ from the actual amounts ultimately realized;

12) Compromise by a malicious actor or other event that causes a loss of secure data from, or inaccessibility to, our computer and other information technology systems;

13) The impact of any reputational damage on the Company including the impact on the Company's ability to attract and retain agents;

14) The severity, magnitude, and impact of natural or man-made catastrophic events, including but not limited to pandemics, tornadoes, hurricanes, earthquakes, war and terrorism, on our operations and personnel, commercial activity and demand for our products; and

15) Globe Life's ability to access the commercial paper and debt markets, particularly if such markets become unpredictable or unstable for a certain period.

Readers are also directed to consider other risks and uncertainties described in other documents on file with the Securities and Exchange Commission, including those described in the "Risk Factors" section of our most recent Annual Report on Form 10-K. Globe Life specifically disclaims any obligation to update or revise any forward-looking statement because of new information, future developments or otherwise.

EARNINGS RELEASE CONFERENCE CALL WEBCAST:

Globe Life will provide a live audio webcast of its first quarter 2025 earnings release conference call with financial analysts at 12:00 pm (Eastern) tomorrow, May1, 2025. Access to the live webcast and replay will be available at on the Calls and Meetings page, at the Conference Calls on the Web icon. Immediately following this press release, supplemental financial reports will be available before the conference call on the Investors page menu of the Globe Life website at "Financial Reports."

APPENDIX


GLOBE LIFE INC.

GAAP CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS



Three Months Ended

March 31,


2025


2024

Revenue:




Life premium

$ 829,863


$ 804,265

Health premium

369,791


341,019

Other premium


Total premium

1,199,654


1,145,284

Net investment income

280,614


282,578

AG˹ٷized gains (losses)

85


(11,799)

Other income

69


76

Total revenue

1,480,422


1,416,139





Benefits and expenses:




Life policyholder benefits(1)

509,756


519,871

Health policyholder benefits(2)

233,929


202,327

Other policyholder benefits

7,080


9,595

Total policyholder benefits

750,765


731,793

Amortization of deferred acquisition costs

105,515


99,478

Commissions, premium taxes, and non-deferred acquisition costs

164,323


148,110

Other operating expense

108,746


93,214

Interest expense

34,992


28,621

Total benefits and expenses

1,164,341


1,101,216





Income before income taxes

316,081


314,923

Income tax benefit (expense)

(61,518)


(60,706)

Net income

$ 254,563


$ 254,217





Basic net income per common share

$ 3.05


$ 2.71





Diluted net income per common share

$ 3.01


$ 2.67



(1)

Net of total remeasurement gain of $8.5 million for the three months ended March 31, 2025, and a total remeasurement gain of $4.9 million for the same period in 2024.

(2)

Net of a total remeasurement gain of $444 thousand for the three months ended March 31, 2025, and a total remeasurement gain of $3.2 million for the same period in 2024.

Cision View original content to download multimedia:

SOURCE Globe Life Inc.

FAQ

How much did Globe Life (GL) earnings per share grow in Q1 2025?

Globe Life's net income per share increased 13% to $3.01, while net operating income per share grew 10% to $3.07 compared to Q1 2024.

What was Globe Life's (GL) insurance premium revenue in Q1 2025?

Globe Life's total insurance premium revenue was $1.2 billion in Q1 2025, with life insurance accounting for $829.9 million (69%) and health insurance for $369.8 million (31%).

How many shares did Globe Life (GL) repurchase in Q1 2025?

Globe Life repurchased 1.5 million shares of common stock at a total cost of $177 million during Q1 2025.

What was Globe Life's (GL) ROE in the first quarter of 2025?

Globe Life achieved a net income ROE of 19.0% and a net operating income ROE (excluding AOCI) of 14.1% for Q1 2025.

How did Globe Life's (GL) agent count perform in Q1 2025?

Globe Life's agent count showed strong growth, with Liberty National up 8% and Family Heritage up 9% compared to Q1 2024.

What was Globe Life's (GL) insurance underwriting margin in Q1 2025?

Life insurance underwriting margin increased 9% to $337.3 million, while health insurance underwriting margin decreased 10% to $84.7 million compared to Q1 2024.
Globe Life Inc

NYSE:GL

GL Rankings

GL Latest News

GL Latest SEC Filings

GL Stock Data

10.30B
82.01M
0.59%
86.45%
1.97%
Insurance - Life
Life Insurance
United States
MCKINNEY